SREE
CHITRA TIRUNAL INSTITUTE
FOR
MEDICAL SCIENCES & TECHNOLOGY
Thiruvananthapuram
– 695 011, Kerala, India.
Tel:
0471 – 2524 437/637 Fax: 0471 2446433/2550728
EMAIL:
projectcell@sctimst.ac.in WEBSITE : http://sctimst.ac.in
P&A/PC/Proj.5201/SCTIMST/2012
dtd. 16.02.2012
PROJECT: Research
Project # 5201 Open-Label Trial to Determine the Long-term Safety to Safinamide
in Parkinson’s disease patients
POST & JOB DETAILS: RESEARCH FELLOW, Full-time
biomedical research.
Conducting
transcranial magnetic stimulation based research studies under supervision of
PI. Candidates will be fully trained in the procedure and will be working along
with clinician and other trained technologists.
VACANCY: One
NATURE AND TENURE OF APPOINTMENT:
Purely on
Contract basis.
One
year (extendable)
REMUNERATION: Consolidated Salary of Rs. 20,000
per month for candidates having B.Tech/M.Tech /M.Sc Physics
Rs.
25,000 per month for candidates having PhD.
AGE LIMIT: Below 35 years as on 29.02.2012.
QUALIFICATION: B.Tech / M.Tech (Biomedical/
Electrical/ Electronics Engineering)/ M.Sc Physics / Diploma in Neurotechnology
/ MD Physiology.
Candidates
with PhD in engineering or physiology can also apply. Candidates with research
interest and who can commit to 3 years work or more will be preferred.
MODE OF SELECTION: WALK-IN-INTERVIEW
DATE & TIME: 11 a.m., Tuesday, 28 February
2012
VENUE: Mini Conference Hall, 3rd Floor,
AMCHSS
Sree
Chitra Tirunal Institute for Medical Sciences and Technology, Medical College Campus,
Trivandrum
REPORTING TIME FOR INTERVIEW:
10 a.m.
Qualified
and interested candidates should report with biodata and certificates in
original to prove their qualification, experience and age at the Project cell,
Achutha Menon Centre for Health Science Studies, Sree Chitra Tirunal Institute
for Medical Sciences and Technology, Medical College Campus, Trivandrum.
FOR
DETAILS, PLEASE REFER http://www.sctimst.ac.in/Recruitment/resources/Research%20Fellow%20(Date%20&%20Time%20of%20Interview%20on%2028-02-2012%20at%2010.00%20AM).pdf
No comments:
Post a Comment